explore our program
Our monoclonal antibodies are designed to target the tumor without harming healthy cells.
leaders in biotherapeutics
Our unique platform, combined with breakthroughs in biotechnology, enable us to produce targeted antibodies that weren’t possible just a few years ago.
Unique Discovery Platform
realize our potential
We have a platform of patient tumor derived anticancer vaccines.